Latest News
Shashi S and David AA Ross of Viteos Fund Services reflect on the ILPA reporting initiative and propose technological solutions…
Increased investor appetite for private equity thanks to outperformance is encouraging institutionalisation of the industry. Against this backdrop the Institutional Limited Partners Association’s (ILPA) reporting template is gaining steam as it aims to deliver standardisation.
However, the absence of an integrated blend of technology with services stymies private equity’s uptake of technology and digitisation in this area, without the right combination the widespread implementation of the new template is likely to be slow.
The industry needs help with this hefty undertaking.
London-based private equity firm Limerston Capital has held the final closing of its debut fund Limerston Capital Partners I with commitments above its GBP200 million target.
The Fund has attracted the support of leading pension funds, endowments and fund of funds with investor geographies covering the United States, Europe and Asia Pacific. In addition, the Limerston team is one of the largest investors in the Fund, demonstrating its close alignment of interests.
The Fund expects to continue to pursue control investments in mid-market companies in the UK with an EBITDA of between GBP4 million and GBP10 million and to
Gangsu Gangtai Holding (Group) Co Ltd, a Chinese group listed on the Shanghai Stock Exchange, has closed its acquisition of 85 per cent stake in Buccellati Holding Italia, which was previously held by Clessidra and the Buccellati family.
The transaction is based on an Equity Value of EUR230 million for 100 per cent of the company.
Buccellati, founded in Milan in 1919, is one of the most prestigious Italian high-end jewellery brands renowned all over the world for its craftsmanship, design and originality. Buccellati jewels are globally admired, not only for their design, but also for the distinctive engraving
Lovell Minnick Partners, a private equity firm specialising in the financial and business services sectors, has appointed Roumi Zlateva as a Vice President.
Zlateva, who will assist with the firm’s evaluation of new investment opportunities, due diligence and transaction structuring, brings broad experience in principal investing and corporate advisory work to her new position at Lovell Minnick. Most recently, she served as Director in the Financial Institutions Group at UBS Securities, providing strategic advice and transaction support to clients in the specialty finance sector.
“Roumi’s skills and experience in corporate advisory, origination and structuring are highly complementary to Lovell
Coinsilium Group Limited, the accelerator that finances and manages the development of early-stage blockchain technology companies, has sold its entire holding of 2,133 shares in investee company SatoshiPay to Blue Star Capital at the price of EUR340 per share for a total consideration in cash of EUR725,220.
Under the terms of the PSA Coinsilium will also receive 85 million warrants over new Ordinary Shares of Blue Star, of which 42.5 million are exercisable at a price of 0.6 pence per Ordinary Share and 42.5 million are exercisable at a price of 0.8 pence per share for a 3-year period from
The Perusa Partners Fund 1 has sold Dynasafe International AB, a specialist in unexploded ordnance clearance and weapons disposal, to Scandinavian investment company Solix Group AB. The parties will not be disclosing further details of the transaction.
Perusa created today’s Dynasafe Group based in Kista (Stockholm), Sweden, in the period between 2009 and 2012 by merging four companies from Germany, Sweden and the United Kingdom: Minetech, BACTEC, GRV Luthe and Dynasafe. The Group subsequently developed into a global brand in the areas of unexploded ordnance clearance, CBRNe safety and weapons disposal with more than 500 employees and contractors. The Group
SHS Gesellschaft für Beteiligungsmanagement is investing in CoreMedic, a start-up developing transfemoral repair systems to treat heart valve malfunctions.
SHS is investing from its fourth fund generation to finance CoreMedic’s further growth and the clinical application of its innovative products.
Mitral heart valve regurgitation (MR) is one of the most common reasons for cardiac failure. The current gold standard therapy is surgical repair by open heart surgery of the arrested heart. CoreMedic is developing ChordArt, a novel heart valve repair system that is less invasive, easy to use, and ,most importantly, will result in an excellent outcome for the
International dispute resolution funder Vannin Capital (Vannin) has recruited three new Investment Directors who will further expand its commercial dispute resolution business in the United States. This is the company’s second office in the US and eighth location globally.
Commercial litigators Michael German from Arnold & Porter Kaye Scholer; Alan Guy from Freshfields Bruckhaus Deringer US and previously Cravath, Swaine & Moore; and Carolina Ramirez from Dentons US and previously White & Case, join Vannin as US Investment Directors.
This is the latest stage in Vannin’s plans to develop its presence in the US following the appointment of Investment
GSK Stockmann has added Arne Bolch to the firm’s Luxembourg team of partners alongside Dr Marcus Peter, Andreas Heinzmann, Dr Philipp Mössner and Mathilde Ostertag, as a new local partner.
Arne Bolch has been working in Luxembourg for more than 11 years in the Luxembourg office of Allen & Overy and more recently at Clifford Chance as counsel. His main areas of expertise include fund formation advice for alternative investment funds (AIF) as well as traditional retail (UCITS) funds. He also assists clients in fund related M&A transactions and general investment fund and regulatory law matters. In the past, Arne advised initiators
FIS has completed the sale of its majority ownership stake in Capco to funds managed by Clayton, Dubilier & Rice (CD&R).
FIS received cash proceeds in the transaction of USD469 million, or USD441 million net of taxes and deal-related expenses. The sale establishes Capco as an independent company.]
CD&R funds purchased approximately 60 per cent equity interest in Capco through the transaction, which includes other consulting-related assets. FIS retains an approximately 40 per cent equity interest in Capco.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
